TransMedics Group Inc (TMDX)
92.10
+2.85
(+3.19%)
USD |
NASDAQ |
Apr 26, 16:00
93.38
+1.28
(+1.39%)
After-Hours: 20:00
TransMedics Group Cash from Financing (TTM): 400.42M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 400.42M |
September 30, 2023 | 402.56M |
June 30, 2023 | 565.26M |
March 31, 2023 | 171.48M |
December 31, 2022 | 167.93M |
September 30, 2022 | 164.91M |
June 30, 2022 | 1.239M |
March 31, 2022 | 1.215M |
December 31, 2021 | 1.393M |
September 30, 2021 | 1.381M |
June 30, 2021 | 0.65M |
Date | Value |
---|---|
March 31, 2021 | 75.98M |
December 31, 2020 | 75.55M |
September 30, 2020 | 75.27M |
June 30, 2020 | 73.02M |
March 31, 2020 | 93.57M |
December 31, 2019 | 92.72M |
September 30, 2019 | 90.69M |
June 30, 2019 | 93.08M |
March 31, 2019 | 22.25M |
December 31, 2018 | 22.06M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.65M
Minimum
Jun 2021
565.26M
Maximum
Jun 2023
134.12M
Average
90.69M
Median
Sep 2019
Cash from Financing (TTM) Benchmarks
SI-BONE Inc | 90.93M |
Cutera Inc | 89.53M |
Stereotaxis Inc | 0.081M |
Electromed Inc | -0.128M |
Myomo Inc | 9.714M |